Genetic Predisposition to In Situ and Invasive Lobular Carcinoma of the Breast

PLoS Genetics

Volumn 10, Issue 4, 2014, Pages

  Sawyer, Elinor ^a   Roylance, Rebecca ^b   Petridis, Christos ^a   Brook, Mark N ^c   Nowinski, Salpie ^a   Papouli, Efterpi ^a   Fletcher, Olivia ^c   Pinder, Sarah ^a   Hanby, Andrew ^d   Kohut, Kelly ^b   Gorman, Patricia ^b   Caneppele, Michele ^b   Peto, Julian ^e   dos Santos Silva, Isabel ^e   Johnson, Nichola ^c   Swann, Ruth ^f   Dwek, Miriam ^f   Perkins, Katherine Anne ^f   Gillett, Cheryl ^a   Houlston, Richard ^c   Ross, Gillian ^g   De Ieso, Paolo ^g   Southey, Melissa C ^h   Hopper, John L ^h   Provenzano, Elena ⁱ   Apicella, Carmel ^h   Wesseling, Jelle ^j   Cornelissen, Sten ^j   Keeman, Renske ^j   Fasching, Peter A ^k,l   Jud, Sebastian M ^l   Ekici, Arif B ^m   Beckmann, Matthias W ^l   Kerin, Michael J ⁿ   Marme, Federick ^o   Schneeweiss, Andreas ^o   Sohn, Christof ^o   Burwinkel, Barbara ^o,p   Guénel, Pascal ^q,r   Truong, Therese ^q,r   Laurent Puig, Pierre ^s   Kerbrat, Pierre ^t   Bojesen, Stig E ^u   Nordestgaard, Børge G ^u   Nielsen, Sune F ^u   Flyger, Henrik ^u   Milne, Roger L ^v   Perez, Jose Ignacio Arias ^w   Menéndez, Primitiva ^w   Benitez, Javier ^v   Brenner, Hermann ^p   Dieffenbach, Aida Karina ^p   Arndt, Volker ^p   Stegmaier, Christa ^x   Meindl, Alfons ^y   Lichtner, Peter ^y   Schmutzler, Rita K ^z   Lochmann, Magdalena ^y   Brauch, Hiltrud ^aa,ab   Fischer, Hans Peter ^ac   Ko, Yon Dschun ^ad   Nevanlinna, Heli ^ah   Muranen, Taru A ^ah   Aittomäki, Kristiina ^ah   Blomqvist, Carl ^ah   Bogdanova, Natalia V ^ai   Dörk, Thilo ^ai   Lindblom, Annika ^aj   Margolin, Sara ^aj   Mannermaa, Arto ^ak,al   Kataja, Vesa ^ak,al   Kosma, Veli Matti ^ak,al   Hartikainen, Jaana M ^ak,al   Chenevix Trench, Georgia ^am   Lambrechts, Diether ^ao,ap   Weltens, Caroline ^aq   Van Limbergen, Erik ^aq   Hatse, Sigrid ^aq   Chang Claude, Jenny ^p   Rudolph, Anja ^p   Seibold, Petra ^p   Flesch Janys, Dieter ^p   Radice, Paolo ^ar,as   Peterlongo, Paolo ^as   Bonanni, Bernardo ^at   Volorio, Sara ^as   Giles, Graham G ^h,au   Severi, Gianluca ^h,au   Baglietto, Laura ^h,au   Mclean, Catriona A ^av   Haiman, Christopher A ^aw   Henderson, Brian E ^aw   Schumacher, Fredrick ^aw   Le Marchand, Loic ^ax   Simard, Jacques ^ay   Goldberg, Mark S ^ag,az   Labrèche, France ^ba   Dumont, Martine ^ay   Kristensen, Vessela ^bb,bc   Winqvist, Robert ^bd   Pylkäs, Katri ^bd   Jukkola Vuorinen, Arja ^be   Kauppila, Saila ^be   Andrulis, Irene L ^an,bf   Knight, Julia A ^bg,bh   Glendon, Gord ^bf   Mulligan, Anna Marie ^an,bi   Devillee, Peter ^bj   Tollenaar, Rob A E M ^bj   Seynaeve, Caroline M ^bk   Kriege, Mieke ^bk   Figueroa, Jonine ^bl   Chanock, Stephen J ^bl   Sherman, Mark E ^bl   Hooning, Maartje J ^bm   Hollestelle, Antoinette ^bm   van den Ouweland, Ans M W ^bk   van Deurzen, Carolien H M ^bk   Li, Jingmei ^bn   Czene, Kamila ^aj   Humphreys, Keith ^aj   Cox, Angela ^bo   Cross, Simon S ^bo   Reed, Malcolm W R ^bo   Shah, Mitul ^af   Jakubowska, Anna ^bp   Lubinski, Jan ^bp   Jaworska Bieniek, Katarzyna ^bp,bq   Durda, Katarzyna ^bp   Swerdlow, Anthony ^c   Ashworth, Alan ^c   Orr, Nicholas ^c   Schoemaker, Minouk ^c   Couch, Fergus J ^br   Hallberg, Emily ^br   González Neira, Anna ^v   Pita, Guillermo ^v   Alonso, M Rosario ^v   Tessier, Daniel C ^ag   Vincent, Daniel ^ag   Bacot, Francois ^ag   Bolla, Manjeet K ^af   Wang, Qin ^af   Dennis, Joe ^af   Michailidou, Kyriaki ^af   Dunning, Alison M ^af   Hall, Per ^aj   Easton, Doug ^af   Pharoah, Paul ^af   Schmidt, Marjanka K ^j   Tomlinson, Ian ^ae   Garcia Closas, Montserrat ^c   more..

^a GUY S HOSPITAL   (United Kingdom)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^c INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^d ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^e LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^f UNIVERSITY OF WESTMINSTER   (United Kingdom)

^g INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^h UNIVERSITY OF MELBOURNE   (Australia)

ⁱ ADDENBROOKE S HOSPITAL   (United Kingdom)

^j ANTONI VAN LEEUWENHOEK HOSPITAL   (Netherlands)

^k UNIVERSITY OF CALIFORNIA   (United States)

^l UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^m UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

ⁿ NATIONAL UNIVERSITY OF IRELAND   (Ireland)

^o UNIVERSITY OF HEIDELBERG   (Germany)

^p GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^q NATIONAL INSTITUTES OF HEALTH   (United States)

^r CENTRE FOR RESEARCH IN EPIDEMIOLOGY AND POPULATION HEALTH   (France)

^s Universites Paris 12 and Paris 6   (France)

^t CENTRE EUGÈNE MARQUIS   (France)

^u Mental Health Services CPH   (Denmark)

^v Centro Nacional de Investigaciones Oncológicas   (Spain)

^w HOSPITAL MONTE NARANCO   (Spain)

^x Saarland Cancer Registry   (Germany)

^y TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^z UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^aa DR MARGARETE FISCHER BOSCH INSTITUTE OF CLINICAL PHARMACOLOGY   (Germany)

^ab UNIVERSITY OF TÜBINGEN   (Germany)

^ac UNIVERSITY OF BONN   (Germany)

^ad Johanniter Krankenhaus   (Germany)

^ae UNIVERSITY OF OXFORD   (United Kingdom)

^af UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^ag MCGILL UNIVERSITY   (Canada)

^ah HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^ai HANNOVER MEDICAL SCHOOL   (Germany)

^aj KAROLINSKA INSTITUTE   (Sweden)

^ak UNIVERSITY OF EASTERN FINLAND   (Finland)

^al KUOPIO UNIVERSITY HOSPITAL   (Finland)

^am QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^an UNIVERSITY OF TORONTO   (Canada)

^ao DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^ap UNIVERSITY OF LEUVEN   (Belgium)

^aq UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^ar NATIONAL CANCER INSTITUTE   (Italy)

^as FIRC INSTITUTE OF MOLECULAR ONCOLOGY   (Italy)

^at EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^au CANCER EPIDEMIOLOGY CENTRE   (Australia)

^av ALFRED HOSPITAL   (Australia)

^aw UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^ax UNIVERSITY OF HAWAII CANCER CENTER   (United States)

^ay Université Laval   (Canada)

^az ROYAL VICTORIA HOSPITAL   (Canada)

^ba UNIVERSITÉ DE MONTRÉAL   (Canada)

^bb OSLO UNIVERSITY HOSPITAL   (Norway)

^bc UNIVERSITY OF OSLO   (Norway)

^bd UNIVERSITY OF OULU   (Finland)

^be OULU UNIVERSITY HOSPITAL   (Finland)

^bf CANCER CARE ONTARIO   (Canada)

^bg MOUNT SINAI HOSPITAL   (Canada)

^bh UNIVERSITY OF TORONTO   (Canada)

^bi UNIVERSITY HEALTH NETWORK   (Canada)

^bj LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^bk ERASMUS MEDICAL CENTER   (Netherlands)

^bl NATIONAL CANCER INSTITUTE   (United States)

^bm ERASMUS MC CANCER INSTITUTE   (Netherlands)

^bn GENOME INSTITUTE OF SINGAPORE   (Singapore)

^bo UNIVERSITY OF SHEFFIELD   (United Kingdom)

^bp POMERANIAN MEDICAL UNIVERSITY   (Poland)

^bq MEDICAL UNIVERSITY OF WARSAW   (Poland)

^br MAYO CLINIC   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR;

ADAM29 GENE; ARTICLE; BREAST CARCINOMA; CANCER SUSCEPTIBILITY; CARCINOMA IN SITU; CDCA7 GENE; CONTROLLED STUDY; DIRC3 GENE; FEMALE; FGFR2 GENE; GENE LOCUS; GENETIC ASSOCIATION; GENETIC DIFFERENCE; GENETIC PREDISPOSITION; GENOTYPE; HISTOPATHOLOGY; HTERT GENE; HUMAN; HUMAN CELL; INTRADUCTAL CARCINOMA; LGR6 GENE; LOBULAR CARCINOMA IN SITU; MAJOR CLINICAL STUDY; MAP3K1 GENE; MLLT10 GENE; ONCOGENE; RAD51L1 GENE; SINGLE NUCLEOTIDE POLYMORPHISM; TERT GENE; TOX3 GENE; TUMOR INVASION; ZMIZ1 GENE; ZNF365 GENE; BREAST TUMOR; CASE CONTROL STUDY; GENETICS; LUNG CARCINOMA; META ANALYSIS; MIDDLE AGED;

BREAST NEOPLASMS; CARCINOMA IN SITU; CARCINOMA, LOBULAR; CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HUMANS; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84901352347     PISSN: 15537390     EISSN: 15537404     Source Type: Journal    
DOI: 10.1371/journal.pgen.1004285     Document Type: Article

References (39)

1. Yoder BJ, Wilkinson EJ, Massoll NA, (2007) Molecular and morphologic distinctions between infiltrating ductal and lobular carcinoma of the breast. Breast J 13 (2) (): 172-79.
2. Reeves GK, Beral V, Green J, Gathani T, (2006) Bull D, (2006) Hormonal therapy for menopause and breast-cancer risk by histological type: a cohort study and meta-analysis. Lancet Oncol 7: 910-918.
3. Kotsopoulos J, Chen WY, Gates MA, Tworoger SS, Hankinson SE, et al. (2010) Risk factors for ductal and lobular breast cancer: results from the nurses' health study. Breast Cancer Res 12: R106.
4. Pestalozzi BC, Zahrieh D, Mallon E, Gusterson BA, Price KN, et al. (2008) Distinct clinical and prognostic features of infiltrating lobular carcinoma of the breast: combined results of 15 International Breast Cancer Study Group clinical trials. J Clin Oncol 26 (18) (): 3006-3014.
5. Cristofanilli M, Gonzalez-Angulo A, Sneige N, Kau SW, Broglio K, et al. (2005) Invasive lobular carcinoma classic type: response to primary chemotherapy and survival outcomes. J Clin Oncol 1;23 (1) (): 41-48.
6. Tubiana-Hulin M, Stevens D, Lasry S, Guinebretière JM, Bouita L, et al. (2006) Response to neoadjuvant chemotherapy in lobular and ductal breast carcinomas:. Ann Oncol 17 (8) (): 1228-1233.
7. Hwang ES, Nyante SJ, Yi Chen Y, Moore D, DeVries S, et al. (2004) Clonality of lobular carcinoma in situ and synchronous invasive lobular carcinoma. Cancer 100 (12) (): 2562-2572.
8. Chuba PJ, Hamre MR, Yap J, Severson RK, Lucas D, et al. (2005) Bilateral risk for subsequent breast cancer after lobular carcinoma-in-situ: analysis of surveillance, epidemiology, and end results data. J Clin Oncol 23 (24) (): 5534-5541.
9. Fisher ER, Land SR, Fisher B, Mamounas E, Gilarski L, et al. (2004) Pathologic findings from the NSABBP: twelve-year observations concerning lobular carcinoma in situ. Cancer 15;100 (2) (): 238-244.
10. Sasson AR, Fowble B, Hanlon AL, Torosian MH, Freedman G, et al. (2001) Lobular carcinoma in situ increases the risk of local recurrence in selected patients with stages I and II breast carcinoma treated with conservative surgery and radiation. Cancer 91: 1862-1869.
11. Easton DF, Pooley KA, Dunning AM, Pharoah PD, Thompson D, et al. (2007) Genome-wide association study identifies novel breast cancer susceptibility loci. Nature 447: 1087-1093.
12. Hunter DJ, Kraft P, Jacobs KB, Cox DG, Yeager M, et al. (2007) A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer. Nat Genet 39: 870-874.
13. Stacey SN, Manolescu A, Sulem P, Rafnar T, Gudmundsson J, et al. (2007) Common variants on chromosomes 2q35 and 16q12 confer susceptibility to estrogen receptor-positive breast cancer. Nat Genet 39: 865-869 (2007).
14. Stacey SN, Manolescu A, Sulem P, Thorlacius S, Gudjonsson SA, et al. (2008) Common variants on chromosome 5p12 confer susceptibility to estrogen receptor-positive breast cancer. Nat Genet 40: 703-706.
15. Ahmed S, Thomas G, Ghoussaini M, Healey CS, Humphreys MK, et al. (2009) Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2. Nat Genet 41: 585-590.
16. Zheng W, Long J, Gao YT, Li C, Zheng Y, Xiang YB, et al. (2009) Genome-wide association study identifies a new breast cancer susceptibility locus at 6q25.1. Nat Genet 41: 324-328.
17. Thomas G, Jacobs KB, Kraft P, Yeager M, Wacholder S, et al. (2009) A multistage genome-wide association study in breast cancer identifies two new risk alleles at 1p11.2 and 14q24.1 (RAD51L1). Nat Genet 41: 579-584.
18. Turnbull C, Ahmed S, Morrison J, Pernet D, Renwick A, et al. (2010) Genome-wide association study identifies five new breast cancer susceptibility loci. Nat Genet 42: 504-507.
19. Antoniou AC, Wang X, Fredericksen ZS, McGuffog L, Tarrell R, et al. (2010) A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor-negative breast cancer in the general population. Nat Genet 42: 885-892.
20. Fletcher O, Johnson N, Orr N, Hosking FJ, Gibson LJ, et al. (2011) Novel breast cancer susceptibility locus at 9q31.2: results of a genome-wide association study. J Natl Cancer Inst 103: 425-435.
21. Haiman CA, Chen GK, Vachon CM, Canzian F, Dunning A, et al. (2011) A common variant at the TERT-CLPTM1L locus is associated with estrogen receptor-negative breast cancer. Nat Genet 43: 1210-1214.
22. Ghoussaini M, Fletcher O, Michailidou K, Turnbull C, Schmidt MK, et al. (2012) Genome-wide association analysis identifies three new breast cancer susceptibility loci. Nat Genet 44: 312-318.
23. Siddiq A, Couch FJ, Chen GK, Lindström S, Eccles D, et al. (2012) A meta-analysis of genome-wide association studies of breast cancer identifies two novel susceptibility loci at 6q14 and 20q11. Hum Mol Genet 21: 5373-5384.
24. Michailidou K, Hall P, Gonzalez-Neira A, Ghoussaini M, Dennis J, et al. (2013) Large-scale genotyping identifies 41 new loci associated with breast cancer risk. Nat Genet 45: 353-361.
25. Garcia-Closas M, Couch FJ, Lindstrom S, Michailidou K, Schmidt MK, et al. (2013) Genome-wide association studies identify four ER negative-specific breast cancer risk loci. Nat Genet 45 (4) (): 392-398.
26. Figueroa JD, Garcia-Closas M, Humphreys M, Platte R, Hopper JL, et al. (2011) Associations of common variants at 1p11.2 and 14q24.1 (RAD51L1) with breast cancer risk and heterogeneity by tumor subtype: findings from the Breast Cancer Association Consortium. Hum Mol Genet 20 (23) (): 4693-706.
27. Cancer Genome Atlas Network (2012) Comprehensive molecular portraits of human breast tumours. Nature 490 (7418) (): 61-70.
28. Osawa T, Muramatsu M, Wang F, Tsuchida R, Kodama T, et al. (2011) Increased expression of histone demethylase JHDM1D under nutrient starvation suppresses tumor growth via down-regulating angiogenesis. PNAS 108 (51) (): 20725-20729.
29. Ibrahim SA, Yip GW, Stock C, Pan JW, Neubauer C, et al. (2012) Targeting of syndecan-1 by microRNA miR-10b promotes breast cancer cell motility and invasiveness via a Rho-GTPase- and E-cadherin-dependent mechanism. Int J Cancer 131 (6) (): E884-896.
30. Pharoah PD, Guilford P, Caldas C, (2001) International Gastric Cancer Linkage Consortium (2001) Incidence of gastric cancer and breast cancer in CDH1 (E-cadherin) mutation carriers from hereditary diffuse gastric cancer families. Gastroenterology 121 (6) (): 1348-53.
31. Xie ZM, Li LS, Laquet C, Penault-Llorca F, Uhrhammer N, et al. (2011) Germline mutations of the E-cadherin gene in families with inherited invasive lobular breast carcinoma but no diffuse gastric cancer. Cancer 117 (14) (): 3112-3117.
32. Weigelt B, Horlings HM, Kreike B, Hayes MM, Hauptmann M, et al. (2008) Refinement of breast cancer classification by molecular characterization of histological special types. J Pathol 216 (2) (): 141-150.
33. Milne RL, Goode EL, García-Closas M, Couch FJ, Severi G, et al. (2011) Confirmation of 5p12 as a susceptibility locus for progesterone-receptor-positive, lower grade breast cancer. Cancer Epidemiol Biomarkers Prev 10: 2222-2231.
34. Pharoah PD, Tsai YY, Ramus SJ, Phelan CM, Goode EL, et al. (2013) GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer. Nat Genet 45: 362-370.
35. Dobbins SE, Broderick P, Melin B, Feychting M, Johansen C, et al. (2011) Common variation at 10p12.31 near MLLT10 influences meningioma risk. Nat Genet 43 (9) (): 825-7.
36. Curtis RE, Benjamin ER, Hankey BF, Hoover RN. New Malignancies Following Breast Cancer. Seer Cancer Registry. Available: http://www.seer.cancer.gov/publications/.
37. Custer BS, Koepsell TD, Mueller BA, (2002) The association between breast carcinoma and meningioma in women. Cancer 94 (6) (): 1626-1635.
38. Swann R, Perkins KA, Velentzis LS, Ciria C, Dutton SJ, et al. (2013) The DietCompLyf study: A prospective cohort study of breast cancer survival and phytoestrogen consumption. Maturitas 3: 232-240.
39. Willer CJ, Li Y, Abecasis GR, (2010) METAL: fast and efficient meta-analysis of genome wide association scans. Bioinformatics 26: 2190-2191.